Focus Groups

The Expert Group is focusing on three areas to develop concrete policy proposals for potential improvements of the European OMP Incentives environment. These areas are:

• Prioritisation and optimisation: addressing therapeutic areas with currently no treatment and to support the delivery of continued innovation for rare diseases where treatments exist
• Regulatory pathways: finding ways to optimize and accelerate regulatory pathways for orphan drugs
• Development incentives: actions tailored to support OD development process, based on other international experience and ideas to trigger collaboration between academia, industry and regulators in Europe